Science Explorer Interactive view Map
Topic · Surgery

Testicular diseases and treatments

Testicular diseases and treatments is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 13.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on testicular germ cell tumors, covering topics such as diagnosis, treatment, long-term survival, chemotherapy, risk factors, and genetic aspects. It also explores complications, including cardiovascular disease, associated with the treatment of testicular cancer.

  • Testicular Cancer
  • Germ Cell Tumors
  • Survivors
  • Chemotherapy
  • Diagnosis
  • Treatment
  • Risk Factors
  • Cryptorchidism
  • Long-Term Complications
  • Genetic Factors
Research works
25k
fractional, since 1950
In the world top 10%
3.3k
per year above
Top-10% rate
13.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+17%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Testicular diseases and treatments research?

By volume, the United States and China publish the most (577 and 402 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 577 works
  2. 2 China 402 works
  3. 3 India 300 works
  4. 4 Japan 163 works
  5. 5 Türkiye 150 works
  6. 6 Germany 136 works
  7. 7 United Kingdom 124 works
  8. 8 Italy 112 works
  9. 9 Brazil 78 works
  10. 10 France 73 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.3%China: 19.0%India: 14.2%Japan: 7.7%6 others listed: 31.8%27%largest
United States577 · 27.3%China402 · 19.0%India300 · 14.2%Japan163 · 7.7%6 others listed672 · 31.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Testicular diseases and treatments research?

By volume in 2022–2025, Sağlık Bilimleri Üniversitesi publishes the most Testicular diseases and treatments research, followed by All India Institute of Medical Sciences and Memorial Sloan Kettering Cancer Center.

By volume, 2022–2025

  1. 1 Sağlık Bilimleri ÜniversitesiTürkiye 16 works
  2. 2 All India Institute of Medical SciencesIndia 15 works
  3. 3 Memorial Sloan Kettering Cancer CenterUnited States 14 works
  4. 4 Indiana University – Purdue University IndianapolisUnited States 13 works
  5. 5 The University of Texas MD Anderson Cancer CenterUnited States 11 works
  6. 6 Sichuan UniversityChina 10 works
  7. 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 10 works
  8. 8 University of Southern CaliforniaUnited States 9 works
  9. 9 University Hospital CologneGermany 9 works
  10. 10 Tata Memorial HospitalIndia 8 works

Where is Testicular diseases and treatments research done?

The largest centres of Testicular diseases and treatments research in 2022–2025 are Beijing (China), London (United Kingdom), Istanbul (Türkiye) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis.

Largest cities, 2022–2025

  1. 1 Beijing China 51 works
  2. 2 London United Kingdom 42 works
  3. 3 Istanbul Türkiye 42 works
  4. 4 New Delhi India 37 works
  5. 5 Tokyo Japan 34 works
  6. 6 New York United States 32 works
  7. 7 Mumbai India 31 works
  8. 8 Guangzhou China 30 works
  9. 9 Ankara Türkiye 29 works
  10. 10 Shanghai China 26 works

Where it is the local speciality

  1. IndianapolisUS · 21.6 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Testicular diseases and treatments than the world average.

See Testicular diseases and treatments on the map

Where is the best place to study Testicular diseases and treatments?

Among universities, judged by research, Indiana University – Purdue University Indianapolis, Sağlık Bilimleri Üniversitesi and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 8.11429%fractional works in this node (log) →share in the world top 10% →Indiana University – Purdue University Indianapolis: 13, 21.2%Sağlık Bilimleri Üniversitesi: 16, 2.7%All India Institute of Medical Sciences: 15, 4.4%Mohammed V University: 8, 0.0%University of Southern California: 9, 9.5%Sichuan University: 10, 11.2%Chinese Academy of Medical Sciences & Peking Union Medical College: 10, 7.8%Indiana University –…All India Institute …Sağlık Bilimleri Üni…Mohammed V University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Indiana University – Purdue University IndianapolisUnited States 77.121.2%13.7×13 +36.5%
2 Sağlık Bilimleri ÜniversitesiTürkiye 60.72.7%9.2×16 —
3 All India Institute of Medical SciencesIndia 41.94.4%7.7×15 -9.6%
4 Mohammed V UniversityMorocco 34.40.0%6.6×8 +364.9%
5 University of Southern CaliforniaUnited States 34.29.5%4.1×9 +53.9%
6 Sichuan UniversityChina 28.411.2%1.8×10 +56.3%
7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 26.77.8%3.2×10 +30.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Testicular diseases and treatments research growing?

Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Testicular diseases and treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.